Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 67

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 67
---
 |                        |     |     3,000 |     | 3,090,848 |
| 2023                                       |     |      |     | 440,000 |     |       — |     | 1,111,181 |              |     |   578,214 |               |     | 335,170 |                                        |     |    16,553 |                        |     | 2,481,118 |     |           |
| 2022                                       |     |      |     | 334,872 |     |       — |     |   933,955 |              |     |   946,422 |               |     | 154,041 |                                        |     |    77,765 |                        |     | 2,447,055 |     |           |

(1) Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in Note 9 to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. There can be no assurance that option awards will be exercised or that RSUs or PSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs or PSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target. If the PSUs were instead valued based on the maximum outcome of the applicable performance condition (i.e., based on maximum level performance), the total amount for the PSU awards reported in this column for 2024 would increase as follows: Mr. Stapley from $2,562,934 to $3,844,401; Ms. Chambers from $1,337,183 to $2,005,775; Dr. Febbo from $891,455 to $1,337,183; Dr. Leite from $1,114,319 to $1,617,479; and Ms. McGuire from $1,114,319 to $1,617,479.

(2) The amounts reported in the Non-Equity Incentive Plan Compensation column for 2024 represent annual cash